Variant report
Variant | esv15681 |
---|---|
Chromosome Location | chr8:1574852-1590095 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:36)
- CpG islands (count:1406)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:36 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr8:1583024-1583221 | GM12878 | blood: | n/a | chr8:1583128-1583139 |
2 | BHLHE40 | chr8:1589261-1589514 | K562 | blood: | n/a | chr8:1589361-1589370 chr8:1589362-1589371 chr8:1589355-1589376 chr8:1589361-1589370 |
3 | CEBPB | chr8:1580668-1580977 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr8:1580676-1580906 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr8:1577269-1577487 | HepG2 | liver: | n/a | chr8:1577393-1577404 chr8:1577393-1577406 chr8:1577395-1577406 chr8:1577393-1577406 chr8:1577395-1577404 |
6 | CTCF | chr8:1574740-1574920 | K562 | blood: | n/a | n/a |
7 | CTCF | chr8:1574798-1574892 | MCF-7 | breast: | n/a | n/a |
8 | ELK1 | chr8:1582547-1582567 | Hela-S3 | cervix: | n/a | n/a |
9 | ELK1 | chr8:1589785-1589810 | K562 | blood: | n/a | n/a |
10 | EP300 | chr8:1577960-1577963 | GM12878 | blood: | n/a | n/a |
11 | FOXA1 | chr8:1579869-1580116 | HepG2 | liver: | n/a | chr8:1580014-1580029 |
12 | FOXA1 | chr8:1579783-1580115 | HepG2 | liver: | n/a | chr8:1580014-1580029 |
13 | FOXA1 | chr8:1579905-1580112 | HepG2 | liver: | n/a | chr8:1580014-1580029 |
14 | FOXA1 | chr8:1579880-1580100 | T-47D | breast: | n/a | chr8:1580014-1580029 |
15 | FOXA1 | chr8:1579862-1580193 | HepG2 | liver: | n/a | chr8:1580014-1580029 |
16 | FOXA1 | chr8:1581553-1581686 | T-47D | breast: | n/a | n/a |
17 | FOXA2 | chr8:1579857-1580107 | HepG2 | liver: | n/a | n/a |
18 | JUND | chr8:1581537-1581603 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | KAP1 | chr8:1581265-1582253 | U2OS | brain: | n/a | chr8:1581849-1581857 |
20 | KAP1 | chr8:1581108-1582241 | HEK293 | kidney: | n/a | chr8:1581849-1581857 |
21 | MAX | chr8:1589296-1589441 | K562 | blood: | n/a | chr8:1589356-1589375 chr8:1589359-1589372 |
22 | MYC | chr8:1580041-1580126 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | POLR2A | chr8:1588534-1588638 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr8:1587955-1588306 | PFSK-1 | brain: | n/a | n/a |
25 | POLR2A | chr8:1581113-1581162 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr8:1587027-1587070 | MCF-7 | breast: | n/a | n/a |
27 | POLR2A | chr8:1581057-1581091 | A549 | lung: | n/a | n/a |
28 | POLR2A | chr8:1581071-1581109 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr8:1581183-1581189 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr8:1581204-1581209 | MCF-7 | breast: | n/a | n/a |
31 | RAD21 | chr8:1574661-1575044 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | RAD21 | chr8:1574835-1575025 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | RFX5 | chr8:1584888-1584906 | K562 | blood: | n/a | n/a |
34 | TAF1 | chr8:1575781-1577038 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | TEAD4 | chr8:1575824-1576296 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | TEAD4 | chr8:1575758-1576720 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:1585929-1585979 | ProgFib | skin: | n/a |
2 | chr8:1580998-1581048 | NB4 | blood: | n/a |
3 | chr8:1585876-1585926 | SKMC | muscle: | n/a |
4 | chr8:1585929-1585979 | ProgFib | skin: | n/a |
5 | chr8:1580998-1581048 | NB4 | blood: | n/a |
6 | chr8:1585876-1585926 | SKMC | muscle: | n/a |
7 | chr8:1580998-1581048 | HCM | heart: | n/a |
8 | chr8:1581598-1581648 | SAEC | small airway: | n/a |
9 | chr8:1575750-1575800 | NH-A | brain: | n/a |
10 | chr8:1588899-1588949 | IMR90 | lung: | fetal |
11 | chr8:1588899-1588949 | HCF | heart: | n/a |
12 | chr8:1589365-1589415 | GM19239 | blood: | n/a |
13 | chr8:1588822-1588872 | MCF-7 | breast: | n/a |
14 | chr8:1581647-1581697 | HL-60 | blood: | n/a |
15 | chr8:1585929-1585979 | SKMC | muscle: | n/a |
16 | chr8:1579180-1579230 | ECC-1 | luminal epithelium: | n/a |
17 | chr8:1588403-1588453 | PANC-1 | pancreas: | n/a |
18 | chr8:1588618-1588668 | HCF | heart: | n/a |
19 | chr8:1585146-1585196 | PrEC | prostate: | n/a |
20 | chr8:1585260-1585310 | AG04450 | lung: | fetal |
21 | chr8:1575750-1575800 | NT2-D1 | testis: | n/a |
22 | chr8:1585876-1585926 | U87 | brain: | n/a |
23 | chr8:1581598-1581648 | HPAEpiC | pulmonary alveolar: | n/a |
24 | chr8:1585876-1585926 | BE2_C | brain: | n/a |
25 | chr8:1581568-1581618 | HNPCEpiC | eye: | n/a |
26 | chr8:1581647-1581697 | HRE | kidney: | n/a |
27 | chr8:1575750-1575800 | PrEC | prostate: | n/a |
28 | chr8:1588618-1588668 | GM06990 | blood: | n/a |
29 | chr8:1579180-1579230 | BE2_C | brain: | n/a |
30 | chr8:1579108-1579158 | NB4 | blood: | n/a |
31 | chr8:1588822-1588872 | HL-60 | blood: | n/a |
32 | chr8:1589365-1589415 | HCT-116 | colon: | n/a |
33 | chr8:1581568-1581618 | AG09309 | skin: | n/a |
34 | chr8:1588618-1588668 | HNPCEpiC | eye: | n/a |
35 | chr8:1589165-1589215 | ECC-1 | luminal epithelium: | n/a |
36 | chr8:1585146-1585196 | BJ | skin: | n/a |
37 | chr8:1589165-1589215 | Hela-S3 | cervix: | n/a |
38 | chr8:1588899-1588949 | AG04450 | lung: | fetal |
39 | chr8:1581122-1581172 | HNPCEpiC | eye: | n/a |
40 | chr8:1579108-1579158 | SAEC | small airway: | n/a |
41 | chr8:1579180-1579230 | SK-N-SH | brain: | n/a |
42 | chr8:1579240-1579290 | ProgFib | skin: | n/a |
43 | chr8:1579108-1579158 | BJ | skin: | n/a |
44 | chr8:1575750-1575800 | GM19239 | blood: | n/a |
45 | chr8:1581568-1581618 | HCT-116 | colon: | n/a |
46 | chr8:1581647-1581697 | SAEC | small airway: | n/a |
47 | chr8:1581568-1581618 | Caco-2 | colon: | n/a |
48 | chr8:1581122-1581172 | SK-N-SH_RA | brain: | n/a |
49 | chr8:1581568-1581618 | IMR90 | lung: | fetal |
50 | chr8:1585146-1585196 | PANC-1 | pancreas: | n/a |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253267 | TF binding region |
ENSG00000253267 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373138047 | chr8:1574856-1574857 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs376444126 | chr8:1574861-1574862 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs143122788 | chr8:1574862-1574863 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs373116852 | chr8:1574863-1574864 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs370942530 | chr8:1574864-1574865 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs376109941 | chr8:1574865-1574866 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs191979855 | chr8:1574868-1574869 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs140146630 | chr8:1574875-1574876 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs201613336 | chr8:1574888-1574889 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs201344779 | chr8:1574902-1574903 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs201567259 | chr8:1574930-1574931 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs374464115 | chr8:1574931-1574932 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs183392303 | chr8:1574933-1574934 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs372268662 | chr8:1574940-1574941 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs375286090 | chr8:1574946-1574947 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs571027498 | chr8:1574960-1574961 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs540100960 | chr8:1574965-1574966 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs368188126 | chr8:1574966-1574967 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs372456654 | chr8:1574969-1574970 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs377198976 | chr8:1574980-1574981 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs2272625 | chr8:1574981-1574982 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs201068222 | chr8:1574992-1574993 | Genic enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs2472082 | chr8:1575005-1575006 | Genic enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs371441823 | chr8:1575018-1575019 | Genic enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs535219758 | chr8:1575027-1575028 | Genic enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs141198040 | chr8:1575047-1575048 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575107102 | chr8:1575058-1575059 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368996807 | chr8:1575059-1575060 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372961257 | chr8:1575062-1575063 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375928713 | chr8:1575067-1575068 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369620454 | chr8:1575068-1575069 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564428422 | chr8:1575089-1575090 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs80120802 | chr8:1575091-1575092 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376995517 | chr8:1575105-1575106 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553408868 | chr8:1575110-1575111 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577924716 | chr8:1575116-1575117 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138985315 | chr8:1575120-1575121 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528493496 | chr8:1575130-1575131 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78610085 | chr8:1575181-1575182 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560331767 | chr8:1575182-1575183 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35821406 | chr8:1575196-1575197 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs188043535 | chr8:1575197-1575198 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193248222 | chr8:1575198-1575199 | Genic enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75404598 | chr8:1575233-1575234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562984147 | chr8:1575236-1575237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184454924 | chr8:1575250-1575251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149880024 | chr8:1575251-1575252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550807201 | chr8:1575259-1575260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555059506 | chr8:1575272-1575273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117088900 | chr8:1575286-1575287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20932292 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ependymoma | 20639864 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1570400-1579800 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
2 | chr8:1574800-1575200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:1575000-1575200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
4 | chr8:1575200-1575400 | Enhancers | Spleen | Spleen |
5 | chr8:1575200-1599400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:1579800-1580000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr8:1579800-1581200 | Enhancers | Fetal Brain Male | brain |
8 | chr8:1580000-1580800 | Enhancers | Fetal Brain Female | brain |
9 | chr8:1580600-1581000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr8:1580800-1581200 | Active TSS | Gastric | stomach |
11 | chr8:1581400-1581800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |